- Location
2
results for "
Myelodysplastic Syndromes
"-
Switzerland-Based Celgene International SáRl Has Received Approval From The EC
Jun 20, 2013Switzerland-based Celgene International Sárl has received approval from the European Commission (EC) to allow its Revlimid drug to treat patients with transfusion-dependent anaemia. While other remedial options could not yield ...
-
Apogenix's Apocept Has Won FDA Orphan Drug Designation to Treat MDS
Feb 18, 2013Clinical stage biopharmaceutical company Apogenix's Apocept (APG101) has won FDA orphan drug designation to treat myelodysplastic syndromes (MDS). Apogenix also announced the commencement of Apocept Phase I trial in MDS patients in ...
Tags: FDA, orphan drug, biopharmaceutical
